Outcomes in the management of vascular prosthetic graft infections confined to the groin: a reappraisal.
The management of vascular prosthetic graft infections confined to the groin continues to be controversial. To critically evaluate this problem, we reviewed the records of our vascular registry from December 1992 through February 1995 and found 17 incidences of groin sepsis involving a vascular prosthesis in 10 patients. These included a proximal prosthetic femoropopliteal bypass (n = 6), an aortobifemoral graft limb (n = 5), an ileofemoral bypass (n = 3), a prosthetic femoral patch (n = 2), and an aortofemoral/femorofemoral bypass (n = 1). The mean age of these patients was 65 years. Six patients were diabetic, four were on systemic steroids, and two were diabetic and on steroids. All infections were Szilagyi grade III including three in which the patients presented with local hemorrhage. Treatment consisted of irrigation, radical debridement with or without in situ graft replacement, and local rotational muscle flap coverage in nine cases, graft excision with extra-anatomic (obturator ileofemoral bypass) graft replacement in six cases, and excision alone in two cases. Of the 17 infections treated operatively and followed from 1 week to 18 months (median 5 months), eight (47%) showed no evidence of recurrence, six (35%) recurred, two (12%) caused early death, and one resulted in a thrombosed graft requiring extra-anatomic reconstruction. Of the nine infected grafted treated locally with muscle flaps, six showed recurrent infection from 3 weeks to 15 months and one thrombosed for a total local treatment failure rate of 78%. Only two grafts are free of infection at 4 and 5 months, respectively. Of the six incidences of infection treated with obturator bypass, four (66%) are free of infection and two resulted in patient death; both infections treated with excision alone were eradicated but resulted in a major lower extremity amputation. These data question the growing acceptance of debridement and local muscle flap coverage for the treatment of all prosthetic vascular graft infections confined to the groin, especially in patients who are diabetic or on systemic steroids.
Taylor
S M
SM
Department of Surgical Education, Greenville Hospital System, SC 29605, USA.
Weatherford
D A
DA
Langan
E M
EM
Lokey
J S
JS
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D001011:Aorta / Q000601:surgery; D001424:Bacterial Infections / Q000601:surgery*; D001807:Blood Vessel Prosthesis / Q000009:adverse effects*; D003646:Debridement; D048909:Diabetes Complications; D005260:Female; D005263:Femoral Artery / Q000601:surgery; D005500:Follow-Up Studies; D006083:Graft Occlusion, Vascular / Q000209:etiology; D006470:Hemorrhage / Q000628:therapy; D006801:Humans; D007083:Iliac Artery / Q000601:surgery; D015994:Incidence; D007264:Inguinal Canal / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000637:transplantation; D011150:Popliteal Artery / Q000601:surgery; D016459:Prosthesis-Related Infections / Q000601:surgery*; D012008:Recurrence; D012042:Registries; D012086:Reoperation; D013524:Surgical Flaps; D007507:Therapeutic Irrigation; D013927:Thrombosis / Q000209:etiology; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones